|Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’drug delivery systems|
European journal of pharmaceutical sciences 11, S93-S98, 2000
|Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system|
European journal of pharmaceutical sciences 29 (3-4), 278-287, 2006
|Strategies to address low drug solubility in discovery and development|
HD Williams, NL Trevaskis, SA Charman, RM Shanker, WN Charman, ...
Pharmacological reviews 65 (1), 315-499, 2013
|Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies|
CW Pouton, CJH Porter
Advanced drug delivery reviews 60 (6), 625-637, 2008
|Formulation of self-emulsifying drug delivery systems|
Advanced drug delivery reviews 25 (1), 47-58, 1997
|Enhancing intestinal drug solubilisation using lipid-based delivery systems|
CJH Porter, CW Pouton, JF Cuine, WN Charman
Advanced drug delivery reviews 60 (6), 673-691, 2008
|Key issues in non-viral gene delivery|
CW Pouton, LW Seymour
Advanced drug delivery reviews 46 (1-3), 187-203, 2001
|The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.|
RD Cone, D Lu, S Koppula, DI Vage, H Klungland, B Boston, W Chen, ...
Recent progress in hormone research 51, 287-317; discussion 318, 1996
|Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound|
SA Charman, WN Charman, MC Rogge, TD Wilson, FJ Dutko, CW Pouton
Pharmaceutical research 9 (1), 87-93, 1992
|Biosynthetic polyhydroxyalkanoates and their potential in drug delivery|
CW Pouton, S Akhtar
Advanced Drug Delivery Reviews 18 (2), 133-162, 1996
|NKX2-5 eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes|
DA Elliott, SR Braam, K Koutsis, ES Ng, R Jenny, EL Lagerqvist, C Biben, ...
Nature methods 8 (12), 1037-1040, 2011
|Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification|
International Journal of Pharmaceutics 27 (2-3), 335-348, 1985
|Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids|
CW Pouton, P Lucas, BJ Thomas, AN Uduehi, DA Milroy, SH Moss
Journal of controlled release 53 (1-3), 289-299, 1998
|Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility|
DB Warren, H Benameur, CJH Porter, CW Pouton
Journal of drug targeting 18 (10), 704-731, 2010
|Influence of lipolysis on drug absorption from the gastro-intestinal tract|
KJ MacGregor, JK Embleton, JE Lacy, EA Perry, LJ Solomon, H Seager, ...
Advanced Drug Delivery Reviews 25 (1), 33-46, 1997
|Targeted delivery to the nucleus|
CW Pouton, KM Wagstaff, DM Roth, GW Moseley, DA Jans
Advanced drug delivery reviews 59 (8), 698-717, 2007
|50 years of oral lipid-based formulations: provenance, progress and future perspectives|
OM Feeney, MF Crum, CL McEvoy, NL Trevaskis, HD Williams, ...
Advanced drug delivery reviews 101, 167-194, 2016
|Embryonic stem cells as a source of models for drug discovery|
CW Pouton, JM Haynes
Nature Reviews Drug Discovery 6 (8), 605-616, 2007
|Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a …|
HD Williams, P Sassene, K Kleberg, JC Bakala-N'Goma, M Calderone, ...
Journal of pharmaceutical sciences 101 (9), 3360-3380, 2012
|Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs|
JF Cuine, CL McEvoy, WN Charman, CW Pouton, GA Edwards, ...
Journal of pharmaceutical sciences 97 (2), 995-1012, 2008